Aficamten
- Generic Name
- Aficamten
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H19N5O2
- CAS Number
- 2364554-48-1
- Unique Ingredient Identifier
- B1I77MH6K1
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
Phase 2
Recruiting
- Conditions
- PediatricSymptomatic Obstructive Hypertrophic Cardiomyopathy
- Interventions
- Drug: AficamtenDrug: Placebo
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Cytokinetics
- Target Recruit Count
- 40
- Registration Number
- NCT06412666
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Children's Hospital Colorado, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath